Bemarituzumab

A4DAB039 | Cancer | Phase-III
FGFR2/CD332
G1 / IgG1
Five Prime Therapeutics ZAI Lab
Phase-III
Whole mAb
AMG-552 AMG552 FPA-144 FPA144
—
Avg A4D Score
-0.603
Score Range
-0.65 to -0.58
Structures
4
Avg. A4D Score per Structure
pH at Min / Max Aggregation Propensity

Associated Structural Profiles Level 2

Structure ID Source PDB Seq. Identity Avg. A4D Score pH (Min Agg.) pH (Max Agg.) Score CDR Score non-CDR
A4DAB039_7sob_N_O 7sob 67% -0.5846 7.0 4.0 -0.092 -0.7375
A4DAB039_7sob_G_I 7sob 67% -0.5993 7.0 4.0 -0.1145 -0.7497
A4DAB039_7sob_H_J 7sob 67% -0.5791 7.0 4.0 -0.0945 -0.7295
A4DAB039_7soc_H_L 7soc 67% -0.649 7.5 4.0 -0.1761 -0.7916